Ferré Sergi, Winkelman John W, García-Borreguero Diego, Belcher Annabelle M, Chang Joy H, Earley Christopher J
Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
Departments of Psychiatry and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Sleep. 2024 Mar 11;47(3). doi: 10.1093/sleep/zsad273.
Restlessness is a core symptom underlying restless legs syndrome (RLS), neuroleptic-induced akathisia, and opioid withdrawal. These three conditions also share other clinical components suggesting some overlap in their pathophysiology. Recent prospective studies demonstrate the frequent incidence of RLS-like symptoms during opioid withdrawal and supervised prescription opioid tapering. Based on the therapeutic role of µ-opioid receptor (MOR) agonists in the three clinical conditions and recent preclinical experimental data in rodents, we provide a coherent and unifying neurobiological basis for the restlessness observed in these three clinical syndromes and propose a heuristic hypothesis of a key role of the specific striatal neurons that express MORs in akathisia/restlessness.
坐立不安是不宁腿综合征(RLS)、抗精神病药物所致静坐不能和阿片类药物戒断的核心症状。这三种情况还具有其他临床特征,提示其病理生理学存在一些重叠。最近的前瞻性研究表明,在阿片类药物戒断和监督下逐渐减少处方阿片类药物剂量期间,RLS样症状频繁出现。基于μ-阿片受体(MOR)激动剂在这三种临床情况中的治疗作用以及最近在啮齿动物中的临床前实验数据,我们为在这三种临床综合征中观察到的坐立不安提供了一个连贯统一的神经生物学基础,并提出了一个启发式假说,即表达MOR的特定纹状体神经元在静坐不能/坐立不安中起关键作用。